PSMA PET scan for recurrent meningioma
Part of Brain & nervous system, Cancer clinical trials.
This study uses a special PET scan to see if your recurrent meningioma has a protein called PSMA. This could help decide if a new treatment that targets this protein might work for you.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have a meningioma that has come back after previous treatment like surgery, radiation, or medication.
- You are willing to sign a consent form.
- You are enrolled in a health insurance plan.
- You have not had anti-angiogenic treatment (a type of targeted therapy) in the last 60 days.
- You are not pregnant, breastfeeding, or planning to become pregnant during the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial uses a special PET scan to find active tumor areas and then delivers a stronger dose of radiation to those spots. It is for people with aggressive or returning meningiomas who have not had brain radiation before.
This study uses a special PET scan (DOTATATE) to help doctors plan radiation treatment for meningioma, a type of brain tumor. The scan may help target radiation more precisely, potentially improving outcomes.
This trial tests whether a special PET scan (called PSMA, which pictures prostate cancer cells) can help doctors better find any remaining or spread of prostate cancer when your PSA level is rising again. It's for people who are planning radiation therapy, and the goal is to see if the scan changes the treatment plan.
This trial looks at using a PSMA PET/CT scan to better re-check cancer activity in men whose PSA has started rising after prostate removal. If you qualify, the scan may help doctors choose the next best treatment step.
This trial looks at how well a special PET scan (called PSMA PET) can find prostate cancer that has come back after treatment. It uses a radioactive tracer to spot cancer cells. Your doctor may already have ordered this scan as part of your regular care.
This trial uses a special PET scan (PSMA PET) to check if prostate cancer returns after focused treatment (focal therapy). It may help find any remaining cancer that standard scans miss.
Hear when a new Meningioma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.